Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Rivaroxaban 20 mg tablets under fed conditions in healthy Thai volunteers
TCTR20221018007Phase 1Completed
- Sponsor
- Bio-innova
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by Bio-innova. Started Apr 2023; status: completed.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20221018007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221018007.